Symrise AG Stock Timeline

TickerSY1.XETRA
Current Price –
Symrise AG – stock chart

Five-year timeline for Symrise AG (SY1.XETRA): major events, developments and context behind the stock's recent history.

View full stock analysis →

5-year stock timeline

2026 October — Q3 and Nine-Month Results

Symrise reported organic sales growth of 5.3% in Q3 2026 and 3.0% for the nine-month period, completing the divestment of its Terpenes business and the acquisition of Floral Concept. The company reaffirmed its full-year 2026 outlook for organic growth of 2–4%, adjusted EBITDA margin of 21.5–22.5%, and adjusted business free cash flow margin above 14%. Investors perceived accelerating momentum after a subdued 2025, viewing management's portfolio-sharpening strategy—divesting lower-return assets while acquiring selective naturals and premium businesses—as evidence of a compounder narrative centered on margin improvement in naturals, fragrances and premium segments [11][12].

2026 Full Year — Annual Report 2025

Symrise published its Corporate Report 2025 and announced an inaugural €400 million share buyback alongside a proposed dividend increase to €1.25 per share. FY2025 Group sales reached €4,929 million with organic sales growth of 2.8% and adjusted EBITDA margin of 21.9%, up 120 basis points year-over-year. Adjusted Business Free Cash Flow totaled €780 million, representing a 15.8% margin. Management framed 2025 as a profitability and cash-flow inflection following prior portfolio moves, emphasizing sustainable margin expansion through the ONE SYM transformation. The 2026 outlook projected organic growth of 2.0–4.0% and adjusted EBITDA margin of 21.5–22.5%. Market perception shifted toward viewing Symrise as disciplined in capital allocation alongside organic improvement [1][3][9].

2025 — H1 Results and Portfolio Actions

Symrise reported H1 2025 organic growth of approximately 3.1% and adjusted EBITDA margin of 21.7%, with recurring cost savings identified from the ONE SYM program. The company divested the Aqua Feed site in Costa Rica (closing June 30, 2025) and initiated divestment of the Terpenes business as part of portfolio optimization. A loss of €1.7 million was recognized on the Costa Rica sale. Management identified efficiency savings of €40 million for 2025, with €20 million realized in the first half. Investors increasingly viewed Symrise as concentrating on higher-return fragrance, food and beverage, and naturals businesses while improving operational efficiency. Sentiment shifted from top-line recovery toward quality of earnings and cash generation [7][14].

2024–2025 — M&A and Stake Acquisitions

On November 20, 2024, Symrise announced a proposal to acquire the remaining 30.35% stake in Probi AB for SEK 1.2 billion, with closing actions occurring in 2025. The company continued targeted acquisitions to strengthen naturals, scent and care, and pet nutrition capabilities. Investors interpreted this dealmaking as strategic vertical integration in probiotics and pet nutrition alongside strengthening of taste and fragrance capabilities, viewing these as bolt-on transactions supporting long-term growth and product differentiation. FY2024 Group sales reached €4,999 million with EBITDA margin of 20.7% [15][2][3].

2021–2023 — Post-Pandemic Recovery and Sensient Acquisition

In 2021 Symrise completed the acquisition of Sensient's Fragrance and Aroma Chemicals business, expanding its fragrance portfolio. The period from 2021 to 2023 delivered strong organic growth and margin recovery. FY2022 sales reached €4,618 million with organic sales growth of 11.4%, while FY2023 sales totaled €4,730 million with organic growth of 7.9%. Investors perceived Symrise as a growth compounder benefiting from recovery in food and beverage and fragrance demand, accelerating naturals exposure, and successful acquisition integration. The market rewarded improving top-line momentum and margin expansion [5][3][2].

Get More Stock Analyses Like This

Receive hand-picked stock recommendations with detailed analyses every week

Start Free Trial
© Leeway
PWP Leeway UG (haftungsbeschränkt)
Leeway Icon